search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Enbrel Gets Nod for Pediatric PsO; IL-33 Targeted in Itch

FDA approved Amgen's Enbrel (etanercept) for chronic moderate to severe psoriasis in pediatric patients age 4 to 17. DermCheck App partners with anti-bullying groups Pacer and Not In My Town to help fight bullying and expand acne care. Researchers show that anti-IL-33 antibody reduces itch of poison ivy in mice, and look ahead to human applications in dermatitis, eczema, and psoriasis.

Advertisement

In This Series

View More

Advertisement